ℹ️
🇬🇧
Search
Search for people relevant for "TARGET"
TARGET
Person
Class
Person
Publication
Programmes
Export current view
MUDr. Ondrej Ondič Ph.D.
Academic staff at Faculty of Medicine in Pilsen
58 publications
Publications
publication
Patients with neuregulin 1 (NRG1) rearranged cancer are suitable for the theranostic approach and targeted therapy
2022 |
Faculty of Medicine in Pilsen, Second Faculty of Medicine
publication
Identification of tumors with NRG1 rearrangement, including a novel putative pathogenic UNC5D-NRG1 gene fusion in prostate cancer by data-drilling a de-identified tumor database
2021 |
Faculty of Medicine in Pilsen, Second Faculty of Medicine
publication
The detection of DNA methylation of tumour suppressor genes in cervical high-grade squamous intraepithelial lesion: A prospective cytological-histological correlation study of 70 cases
2019 |
Faculty of Medicine in Pilsen
publication
Inflammatory myofibroblastic tumor of the uterus - case report
2019 |
Faculty of Medicine in Pilsen
publication
Renal Cell Carcinoma With Leiomyomatous Stroma: A Group of Tumors With Indistinguishable Histopathologic Features, But 2 Distinct Genetic Profiles: Next-Generation Sequencing Analysis of 6 Cases Negative for Aberrations Related to the VHL gene
2018 |
Faculty of Medicine in Pilsen
publication
Immunohistochemical and selected genetic reflex testing of all uterine leiomyosarcomas and STUMPs for ALK gene rearrangement may provide an efeective screening tool in identifying uterine ALK-rearranged mesenchymal tumors
2018 |
Faculty of Medicine in Pilsen
publication
Bizarre cell dysplasia of the cervix
2017 |
Faculty of Medicine in Pilsen
publication
Programmed death-1 (PD-1) receptor/PD-1 ligand (PD-L1) expression in fumarate hydratase-deficient renal cell carcinoma
2017 |
Faculty of Medicine in Pilsen
publication
Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a non-endemic eastern european population
2016 |
Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
publication
Genetic testing of leiomyoma tissue in women younger than 30 years old might provide an effective screening approach for the hereditary leiomyomatosis and renal cell cancer syndrome (HLRCC)
2015 |
Faculty of Medicine in Pilsen
Load more publications (48)
Loading network view...